Clinical Trial Update: COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities [Phase 3]

View source ↗

Summary

Phase 3 trial of the SARS-CoV-2 mRNA vaccine CVnCoV in adults with comorbidities was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Syndrome Coronavirus 2 Infection

Drugs mentioned

• CVnCoV (CVnCoV)

Snippet

Sponsor: CureVac | Conditions: Coronavirus, Covid19 | Phase 3 | Status: TERMINATED | Results posted: 2022-05-13